THWETF / Fundabrdn World Healthcare Fund
Verdicts genuinely change. Free email alert the moment THW's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
abrdn World Healthcare Fund
137 holdings · as of 2026-06-30 (4.7 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 122% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT At least 28.22% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 41% turns out to be. Matching more holdings can only raise this share, never lower it.
137 holdings, 77 matched (66% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
1.30% of this portfolio’s income is non-permissible — weighted across holdings, computed over 49% of portfolio weight (52 of 137 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
All holdings (137)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| uniQure NV | UNSCREENED | 6.44% | no in-house ratios for this holding |
| AZN AstraZeneca PLC | COMPLIANT | 4.86% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VeraDermics Inc | UNSCREENED | 4.20% | no in-house ratios for this holding |
| Abivax SA | UNSCREENED | 3.99% | no in-house ratios for this holding |
| SNY Sanofi SA | COMPLIANT | 3.55% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
| VERADERMICS, INC. | UNSCREENED | 3.22% | no in-house ratios for this holding |
| ARGX Argenx SE | COMPLIANT | 3.16% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 3.11% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| ABT Abbott Laboratories | COMPLIANT | 2.92% | AAOIFI16.6% Usmani28.8% Dow Jones Islamic15.7% S&P Shariah16.2% MSCI Islamic28.8% MSCI Islamic M-Series16.2% FTSE Shariah28.8% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 2.80% | AAOIFI20.3% Usmani23.8% Dow Jones Islamic21.8% S&P Shariah19.5% MSCI Islamic23.8% MSCI Islamic M-Series19.5% FTSE Shariah23.8% |
| MDT Medtronic PLC | COMPLIANT | 2.63% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| RO.SW Roche Holding AG | COMPLIANT | 2.53% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| DHR Danaher Corp | COMPLIANT | 2.52% | AAOIFI16.4% Usmani28.4% Dow Jones Islamic18.0% S&P Shariah16.8% MSCI Islamic28.4% MSCI Islamic M-Series16.8% FTSE Shariah28.4% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 2.50% | AAOIFI16.9% Usmani38.0% Dow Jones Islamic22.0% S&P Shariah21.4% MSCI Islamic38.0% MSCI Islamic M-Series21.4% FTSE Shariah38.0% |
| Newamsterdam Pharma Co NV | UNSCREENED | 2.29% | no in-house ratios for this holding |
| OXB | UNSCREENED | 2.16% | no in-house ratios for this holding |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.15% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| MRK Merck & Co Inc | COMPLIANT | 2.13% | AAOIFI15.2% Usmani40.5% Dow Jones Islamic21.0% S&P Shariah20.4% MSCI Islamic40.5% MSCI Islamic M-Series20.4% FTSE Shariah40.5% |
| ProQR Therapeutics NV | UNSCREENED | 2.07% | no in-house ratios for this holding |
| BSX Boston Scientific Corp | COMPLIANT | 2.04% | AAOIFI18.6% Usmani26.3% Dow Jones Islamic10.0% S&P Shariah10.4% MSCI Islamic26.3% MSCI Islamic M-Series10.4% FTSE Shariah26.3% |
| Praxis Precision Medicines Inc | UNSCREENED | 1.94% | no in-house ratios for this holding |
| VTR Ventas Inc | COMPLIANT | 1.79% | AAOIFI27.7% Usmani40.6% Dow Jones Islamic35.7% S&P Shariah41.8% MSCI Islamic40.6% MSCI Islamic M-Series41.8% FTSE Shariah40.6% |
| LONN.SW Lonza Group AG | COMPLIANT | 1.67% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| GPCR Structure Therapeutics Inc | NON_COMPLIANT | 1.67% | AAOIFI0.5% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| WELL Welltower Inc | COMPLIANT | 1.61% | AAOIFI10.5% Usmani24.6% Dow Jones Islamic14.6% S&P Shariah17.7% MSCI Islamic24.6% MSCI Islamic M-Series17.7% FTSE Shariah24.6% |
| DTIL Precision BioSciences Inc | NON_COMPLIANT | 1.59% | AAOIFI2.6% Usmani4.4% Dow Jones Islamic5.2% S&P Shariah5.9% MSCI Islamic4.4% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| CVS CVS Health Corp | NON_COMPLIANT | 1.52% | AAOIFI66.4% Usmani29.2% Dow Jones Islamic80.4% S&P Shariah85.9% MSCI Islamic29.2% MSCI Islamic M-Series85.9% FTSE Shariah23.5% |
| HUM Humana Inc | NON_COMPLIANT | 1.51% | AAOIFI23.6% Usmani21.8% Dow Jones Islamic36.9% S&P Shariah34.0% MSCI Islamic21.8% MSCI Islamic M-Series34.0% FTSE Shariah21.8% |
| ALC Alcon AG | COMPLIANT | 1.44% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CRL Charles River Laboratories International Inc | COMPLIANT | 1.22% | AAOIFI17.7% Usmani38.3% Dow Jones Islamic30.3% S&P Shariah28.5% MSCI Islamic38.3% MSCI Islamic M-Series28.5% FTSE Shariah32.8% |
| BAYN.DE Bayer AG | NON_COMPLIANT | 1.19% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| PODD Insulet Corp | COMPLIANT | 1.08% | AAOIFI9.5% Usmani28.2% Dow Jones Islamic5.6% S&P Shariah6.0% MSCI Islamic28.2% MSCI Islamic M-Series6.0% FTSE Shariah28.2% |
| IMUX IMMUNIC | NON_COMPLIANT | 1.05% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| 9688.HK Zai Lab Ltd | NON_COMPLIANT | 1.04% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| UNH UNITEDHEALTH GROUP INC (the issuer's debt, not its shares) | NON_COMPLIANT | 1.04% | no in-house ratios for this holding |
| OCSAW Oculis Holding AG | NON_COMPLIANT | 1.02% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ABT ABBOTT LABORATORIES (the issuer's debt, not its shares) | UNSCREENED | 0.97% | no in-house ratios for this holding |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 0.97% | AAOIFI37.4% Usmani53.5% Dow Jones Islamic48.0% S&P Shariah44.6% MSCI Islamic53.5% MSCI Islamic M-Series44.6% FTSE Shariah52.7% |
| ALC Alcon AG | COMPLIANT | 0.97% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ICLR ICON PLC | COMPLIANT | 0.94% | AAOIFI22.8% Usmani21.6% Dow Jones Islamic26.9% S&P Shariah20.7% MSCI Islamic21.6% MSCI Islamic M-Series20.7% FTSE Shariah20.8% |
| Disc Medicine Inc | UNSCREENED | 0.93% | no in-house ratios for this holding |
| PFE PFIZER INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.91% | no in-house ratios for this holding |
| DOC Healthpeak Properties Inc | NON_COMPLIANT | 0.91% | AAOIFI66.9% Usmani41.9% Dow Jones Islamic76.6% S&P Shariah79.8% MSCI Islamic41.9% MSCI Islamic M-Series79.8% FTSE Shariah41.9% |
| ALPHA 9 ONCOLOGY | UNSCREENED | 0.88% | no in-house ratios for this holding |
| RADIANT BIOTHERAPEUTICS INC. | UNSCREENED | 0.88% | no in-house ratios for this holding |
| WGS GeneDx Holdings Corp | COMPLIANT | 0.87% | AAOIFI7.1% Usmani27.8% Dow Jones Islamic5.7% S&P Shariah7.7% MSCI Islamic27.8% MSCI Islamic M-Series7.7% FTSE Shariah27.8% |
| Abivax SA | UNSCREENED | 0.86% | no in-house ratios for this holding |
| State Street Global Advisors | UNSCREENED | 0.85% | no in-house ratios for this holding |
| IMUX IMMUNIC INC. | NON_COMPLIANT | 0.84% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| ONT.L Oxford Nanopore Technologies PLC | NON_COMPLIANT | 0.84% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| IMTX Immatics NV | NON_COMPLIANT | 0.83% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| ZBH ZIMMER BIOMET HOLDINGS (the issuer's debt, not its shares) | NON_COMPLIANT | 0.81% | no in-house ratios for this holding |
| Inventiva SACA | UNSCREENED | 0.81% | no in-house ratios for this holding |
| ELV Elevance Health Inc | NON_COMPLIANT | 0.80% | AAOIFI31.9% Usmani24.1% Dow Jones Islamic38.0% S&P Shariah33.6% MSCI Islamic24.1% MSCI Islamic M-Series33.6% FTSE Shariah24.1% |
| 2268.HK WuXi XDC Cayman Inc | COMPLIANT | 0.78% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| JNJ JOHNSON & JOHNSON (the issuer's debt, not its shares) | UNSCREENED | 0.77% | no in-house ratios for this holding |
| AgomAb Therapeutics NV | UNSCREENED | 0.72% | no in-house ratios for this holding |
| WAT Waters Corp | COMPLIANT | 0.71% | AAOIFI10.7% Usmani20.1% Dow Jones Islamic17.9% S&P Shariah19.8% MSCI Islamic20.1% MSCI Islamic M-Series19.8% FTSE Shariah18.6% |
| IMUX IMMUNIC INC. | NON_COMPLIANT | 0.65% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| ORNBV.HE Orion Oyj | COMPLIANT | 0.63% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| IMUX IMMUNIC | NON_COMPLIANT | 0.63% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| Diaceutics Plc | UNSCREENED | 0.63% | no in-house ratios for this holding |
| TMO THERMO FISHER SCIENTIFIC (the issuer's debt, not its shares) | UNSCREENED | 0.61% | no in-house ratios for this holding |
| OHI Omega Healthcare Investors Inc | COMPLIANT | 0.60% | AAOIFI28.2% Usmani39.7% Dow Jones Islamic34.3% S&P Shariah39.3% MSCI Islamic39.7% MSCI Islamic M-Series39.3% FTSE Shariah39.7% |
| MOH Molina Healthcare Inc | NON_COMPLIANT | 0.58% | AAOIFI32.7% Usmani25.2% Dow Jones Islamic31.9% S&P Shariah25.7% MSCI Islamic24.1% MSCI Islamic M-Series25.7% FTSE Shariah24.1% |
| ROCHE HOLDINGS INC | UNSCREENED | 0.56% | no in-house ratios for this holding |
| INSP Inspire Medical Systems Inc | COMPLIANT | 0.55% | AAOIFI1.7% Usmani3.0% Dow Jones Islamic0.9% S&P Shariah0.7% MSCI Islamic3.0% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| MCK McKesson Corp | COMPLIANT | 0.55% | AAOIFI9.5% Usmani12.9% Dow Jones Islamic12.6% S&P Shariah14.0% MSCI Islamic12.9% MSCI Islamic M-Series14.0% FTSE Shariah10.8% |
| ABBV ABBVIE INC (the issuer's debt, not its shares) | UNSCREENED | 0.54% | no in-house ratios for this holding |
| HR Healthcare Realty Trust Inc | NON_COMPLIANT | 0.54% | AAOIFI65.0% Usmani47.4% Dow Jones Islamic73.0% S&P Shariah75.9% MSCI Islamic47.4% MSCI Islamic M-Series75.9% FTSE Shariah47.4% |
| ZTS Zoetis Inc | NON_COMPLIANT | 0.52% | AAOIFI28.0% Usmani61.2% Dow Jones Islamic16.9% S&P Shariah14.7% MSCI Islamic61.2% MSCI Islamic M-Series14.7% FTSE Shariah60.0% |
| ELV ELEVANCE HEALTH INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.51% | no in-house ratios for this holding |
| CI CIGNA GROUP/THE (the issuer's debt, not its shares) | NON_COMPLIANT | 0.51% | no in-house ratios for this holding |
| JAZZ Jazz Pharmaceuticals PLC | NON_COMPLIANT | 0.50% | AAOIFI36.6% Usmani46.9% Dow Jones Islamic54.5% S&P Shariah60.7% MSCI Islamic46.9% MSCI Islamic M-Series60.7% FTSE Shariah46.4% |
| DXCM Dexcom Inc | COMPLIANT | 0.50% | AAOIFI4.4% Usmani22.3% Dow Jones Islamic4.6% S&P Shariah4.0% MSCI Islamic21.5% MSCI Islamic M-Series4.0% FTSE Shariah19.9% |
| CDNA CareDx Inc | COMPLIANT | 0.48% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| SYK Stryker Corp | COMPLIANT | 0.47% | AAOIFI12.8% Usmani32.7% Dow Jones Islamic11.5% S&P Shariah11.8% MSCI Islamic32.7% MSCI Islamic M-Series11.8% FTSE Shariah31.6% |
| SBRA Sabra Health Care REIT Inc | NON_COMPLIANT | 0.47% | AAOIFI45.9% Usmani44.9% Dow Jones Islamic55.9% S&P Shariah62.3% MSCI Islamic44.9% MSCI Islamic M-Series62.3% FTSE Shariah44.9% |
| MAZE Maze Therapeutics Inc | COMPLIANT | 0.45% | AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6% |
| Perceptive Capital Solutions Corp | UNSCREENED | 0.43% | no in-house ratios for this holding |
| SpyGlass Pharma Inc | UNSCREENED | 0.43% | no in-house ratios for this holding |
| CRYSTALYS THERAPEUTICS SER A | UNSCREENED | 0.39% | no in-house ratios for this holding |
| CVS CVS HEALTH CORP (the issuer's debt, not its shares) | NON_COMPLIANT | 0.38% | no in-house ratios for this holding |
| ASND Ascendis Pharma A/S | COMPLIANT | 0.38% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Teva Pharmaceutical Industries Ltd | UNSCREENED | 0.38% | no in-house ratios for this holding |
| ENDEAVOR BIOMEDICINES, INC. | UNSCREENED | 0.35% | no in-house ratios for this holding |
| MOBI Mobia Medical Inc | NON_COMPLIANT | 0.33% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.6% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ALKS Alkermes PLC | COMPLIANT | 0.32% | AAOIFI19.9% Usmani35.4% Dow Jones Islamic27.5% S&P Shariah29.8% MSCI Islamic35.4% MSCI Islamic M-Series29.8% FTSE Shariah33.8% |
| 300347.SZ Hangzhou Tigermed Consulting Co Ltd | COMPLIANT | 0.32% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| DTIL PRECISION BIOSCIENCES | NON_COMPLIANT | 0.32% | AAOIFI2.6% Usmani4.4% Dow Jones Islamic5.2% S&P Shariah5.9% MSCI Islamic4.4% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| BDX Becton Dickinson & Co | NON_COMPLIANT | 0.31% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| MDT MEDTRONIC INC (the issuer's debt, not its shares) | UNSCREENED | 0.28% | no in-house ratios for this holding |
| AMOLYT MILESTONE | UNSCREENED | 0.27% | no in-house ratios for this holding |
| ABBV ABBVIE INC (the issuer's debt, not its shares) | UNSCREENED | 0.26% | no in-house ratios for this holding |
| Seaport Therapeutics Inc | UNSCREENED | 0.22% | no in-house ratios for this holding |
| RVMDW Revolution Medicines Inc | NON_COMPLIANT | 0.19% | AAOIFI49.8% Usmani14.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic14.9% MSCI Islamic M-Series— FTSE Shariah11.3% |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.18% | no in-house ratios for this holding |
| OSE Immuno | UNSCREENED | 0.17% | no in-house ratios for this holding |
| GLAXOSMITHKLINE CAPITAL | UNSCREENED | 0.17% | no in-house ratios for this holding |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.17% | no in-house ratios for this holding |
| DH EUROPE FINANCE II | UNSCREENED | 0.14% | no in-house ratios for this holding |
| IMUX Immunic Inc | NON_COMPLIANT | 0.13% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| SDZ.SW Sandoz Group AG | COMPLIANT | 0.12% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| LIVN LivaNova PLC | COMPLIANT | 0.11% | AAOIFI7.0% Usmani13.0% Dow Jones Islamic10.8% S&P Shariah11.4% MSCI Islamic13.0% MSCI Islamic M-Series11.4% FTSE Shariah10.9% |
| ODTX Odyssey Therapeutics Inc | NON_COMPLIANT | 0.10% | AAOIFI2.5% Usmani5.4% Dow Jones Islamic— S&P Shariah— MSCI Islamic5.4% MSCI Islamic M-Series— FTSE Shariah0.0% |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.10% | AAOIFI0.6% Usmani0.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.9% MSCI Islamic M-Series— FTSE Shariah0.0% |
| Renalytix PLC | UNSCREENED | 0.10% | no in-house ratios for this holding |
| ENDEAVOR BIOMEDICINES INC. | UNSCREENED | 0.09% | no in-house ratios for this holding |
| InspireMD Inc | UNSCREENED | 0.09% | no in-house ratios for this holding |
| ENGRAIL THERAPEUTICS INC. SERI | UNSCREENED | 0.08% | no in-house ratios for this holding |
| Avalyn Pharma Inc | UNSCREENED | 0.07% | no in-house ratios for this holding |
| Hemab Therapeutics Holdings Inc | UNSCREENED | 0.06% | no in-house ratios for this holding |
| DBK.DE Deutsche Bank AG | NON_COMPLIANT | 0.05% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| Goldman Sachs International | UNSCREENED | 0.03% | no in-house ratios for this holding |
| QNRX Quoin Pharmaceuticals Ltd | NON_COMPLIANT | 0.03% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| OCULIS HOLDINGS AG | UNSCREENED | 0.03% | no in-house ratios for this holding |
| Morgan Stanley & Co. International PLC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Options Clearing Corp. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Citibank NA | UNSCREENED | 0.01% | no in-house ratios for this holding |
| SHIRE ACQ INV IRELAND DA | UNSCREENED | 0.01% | no in-house ratios for this holding |
| RY Royal Bank of Canada | COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| RY Royal Bank of Canada | COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| Morgan Stanley & Co. International PLC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| DBK.DE Deutsche Bank AG | NON_COMPLIANT | 0.00% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| Standard Chartered Bank | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Standard Chartered Bank | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Goldman Sachs International | UNSCREENED | 0.00% | no in-house ratios for this holding |
| RY Royal Bank of Canada | COMPLIANT | 0.00% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| CONTRA FUSION PHARMACE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Morgan Stanley & Co. International PLC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Standard Chartered Bank | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Standard Chartered Bank | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Goldman Sachs International | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Morgan Stanley & Co. International PLC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| PRIOTHERA LIMITED | UNSCREENED | 0.00% | no in-house ratios for this holding |
| IO LIGHT HOLDINIGS, INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
| ESC CB144A MALLINCKROD | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 13 points of portfolio weight — 44.8% of it passes AAOIFI, 32.0% passes Usmani. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 44.8% ratios fail on 21.2% 55.7% not rated under AAOIFI
ratios pass on 32.0% ratios fail on 32.3% 57.3% not rated under Usmani
ratios pass on 39.1% ratios fail on 23.4% 59.1% not rated under Dow Jones Islamic
ratios pass on 39.1% ratios fail on 22.6% 60.0% not rated under S&P Shariah
ratios pass on 32.7% ratios fail on 33.2% 55.7% not rated under MSCI Islamic
ratios pass on 39.1% ratios fail on 23.4% 59.1% not rated under MSCI Islamic M-Series
ratios pass on 36.8% ratios fail on 29.1% 55.7% not rated under FTSE Shariah
62 of 137 listed holdings carry our own per-methodology verdicts (77% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 46 (53% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 2.80% |
| GPCR Structure Therapeutics Inc | 1.67% |
| DTIL Precision BioSciences Inc | 1.59% |
| CVS CVS Health Corp | 1.52% |
| HUM Humana Inc | 1.51% |
| BAYN.DE Bayer AG | 1.19% |
| IMUX IMMUNIC | 1.05% |
| 9688.HK Zai Lab Ltd | 1.04% |
| UNH UNITEDHEALTH GROUP INC | 1.04% |
| OCSAW Oculis Holding AG | 1.02% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
abrdn World Healthcare Fund (THW) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Still fetching analyst coverage — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for THW — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Israel Englander | Millennium Management | $0M | 0.0% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 38.80 | NEUTRAL |
| Stochastic %K (14) | 0.00 | BUY |
| CCI (20) | -125.57 | BUY |
| Williams %R (14) | -100.00 | BUY |
| MACD (12,26,9) | -0.06 | SELL |
| ROC (10) | -7.19 | SELL |
| Momentum (10) | -0.95 | SELL |
| EMA (10) | 12.85 | SELL |
| SMA (10) | 13.01 | SELL |
| EMA (20) | 12.83 | SELL |
| SMA (20) | 12.86 | SELL |
| EMA (30) | 12.81 | SELL |
| SMA (30) | 12.60 | SELL |
| EMA (50) | 12.82 | SELL |
| SMA (50) | 12.75 | SELL |
| EMA (100) | 12.78 | SELL |
| SMA (100) | 13.03 | SELL |
| EMA (200) | 12.35 | SELL |
| SMA (200) | 12.39 | SELL |
About abrdn World Healthcare Fund
Financial Services · Asset Management
Abrdn World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by abrdn Inc. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector. For its fixed income portion, the fund primarily invests in corporate debt securities. Abrdn World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 43 |
| ⏰ 4H | BEARISH | 26 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Still fetching insider filings — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.